Trials / Conditions / Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity
Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity
4 registered clinical trials studyying Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Pri NCT00492089 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidne NCT00101348 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00089362 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and NCT00023959 | National Cancer Institute (NCI) | Phase 1 |